Prelude DX (in partnership with Media Directions)
Female patients with non-invasive
breast cancer (DCIS)
Prelude DX provides laboratory tests for patients with non-invasive breast cancer (DCIS) that help predict the overall benefit of radiation therapy when compared to other treatment modalities including surgery or active surveillance.
Illustrations and iconography were created for use on the Prelude DX website and in printed patient education materials. The purpose of the illustrations was to 1) explain normal anatomy of female breast tissue, 2) depict how DCIS affects a lactiferous duct at the histological level, and 3) contextualize DCIS in relation to invasive breast cancer.
Timeline: 6-8 weeks + revisions
Style: digital color illustration and vector line iconography
Quantity: 5 illustrations and 4 icons
Scientific complexity: medium
Reback Biomedical Media | 608.852.3233 | email@example.com
All content © Reback Biomedical Media, 2015-2021, unless otherwise noted. All rights reserved.